Mobile

Evaluation of the Therapeutic Benefit of an Initial Intensified Dosing Regimen of Mycophenolate Sodium Versus a Standard Regimen in Renal Transplant Patients

Mise à jour : Il y a 4 ans
Référence : NCT00419926

Femme et Homme

  • | Pays :
  • Switzerland
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The purpose of this study is to determine if an initial intensified enteric-coated mycophenolate sodium (Myfortic) dosing regimen administered during the first six weeks post renal transplantation provides improved efficacy, with a similar safety profile, compared to a standard regimen of Myfortic.

Critère d'inclusion

  • Kidney Transplantation

Liens